GLP1R and type 2 diabetes mellitus: In fact, most of the GLP-1 analogues have been demonstrated to delay CVD by exerting pleiotropic and anti-inflammatory effects in the CV system and currently are in the first line for T2DM treatment and the prevention of its complications.